535 related articles for article (PubMed ID: 31298560)
1. Drug-eluting stent specifically designed to target vascular smooth muscle cell phenotypic modulation attenuated restenosis through the YAP pathway.
Huang C; Zhang W; Zhu Y
Am J Physiol Heart Circ Physiol; 2019 Sep; 317(3):H541-H551. PubMed ID: 31298560
[TBL] [Abstract][Full Text] [Related]
2. Drug-Eluting Stent Targeting Sp-1-Attenuated Restenosis by Engaging YAP-Mediated Vascular Smooth Muscle Cell Phenotypic Modulation.
Huang C; Zhao J; Zhu Y
J Am Heart Assoc; 2020 Jan; 9(1):e014103. PubMed ID: 31880978
[TBL] [Abstract][Full Text] [Related]
3. RhoA inhibitor-eluting stent attenuates restenosis by inhibiting YAP signaling.
Huang C; Zhou M; Zheng X
J Vasc Surg; 2019 May; 69(5):1581-1589.e1. PubMed ID: 31010523
[TBL] [Abstract][Full Text] [Related]
4. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088
[TBL] [Abstract][Full Text] [Related]
5. Dedicator of cytokinesis 2, a novel regulator for smooth muscle phenotypic modulation and vascular remodeling.
Guo X; Shi N; Cui XB; Wang JN; Fukui Y; Chen SY
Circ Res; 2015 May; 116(10):e71-80. PubMed ID: 25788409
[TBL] [Abstract][Full Text] [Related]
6. Fludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activation.
Torella D; Curcio A; Gasparri C; Galuppo V; De Serio D; Surace FC; Cavaliere AL; Leone A; Coppola C; Ellison GM; Indolfi C
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2935-43. PubMed ID: 17293493
[TBL] [Abstract][Full Text] [Related]
7. Olfactomedin 2 Regulates Smooth Muscle Phenotypic Modulation and Vascular Remodeling Through Mediating Runt-Related Transcription Factor 2 Binding to Serum Response Factor.
Shi N; Li CX; Cui XB; Tomarev SI; Chen SY
Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):446-454. PubMed ID: 28062493
[TBL] [Abstract][Full Text] [Related]
8. Surfactant Protein A, a Novel Regulator for Smooth Muscle Phenotypic Modulation and Vascular Remodeling-Brief Report.
Ran R; Cai D; King SD; Que X; Bath JM; Chen SY
Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):808-814. PubMed ID: 33267655
[TBL] [Abstract][Full Text] [Related]
9. The induction of yes-associated protein expression after arterial injury is crucial for smooth muscle phenotypic modulation and neointima formation.
Wang X; Hu G; Gao X; Wang Y; Zhang W; Harmon EY; Zhi X; Xu Z; Lennartz MR; Barroso M; Trebak M; Chen C; Zhou J
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2662-9. PubMed ID: 22922963
[TBL] [Abstract][Full Text] [Related]
10. The Role of Tauroursodeoxycholic Acid on Dedifferentiation of Vascular Smooth Muscle Cells by Modulation of Endoplasmic Reticulum Stress and as an Oral Drug Inhibiting In-Stent Restenosis.
Luo H; Zhou C; Chi J; Pan S; Lin H; Gao F; Ni T; Meng L; Zhang J; Jiang C; Ji Z; Lv H; Guo H
Cardiovasc Drugs Ther; 2019 Feb; 33(1):25-33. PubMed ID: 30663009
[TBL] [Abstract][Full Text] [Related]
11. Myocardin regulates vascular response to injury through miR-24/-29a and platelet-derived growth factor receptor-β.
Talasila A; Yu H; Ackers-Johnson M; Bot M; van Berkel T; Bennett MR; Bot I; Sinha S
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2355-65. PubMed ID: 23825366
[TBL] [Abstract][Full Text] [Related]
12. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
[TBL] [Abstract][Full Text] [Related]
13. A perlecan-inducing compound significantly inhibits smooth muscle cell function and in-stent intimal hyperplasia: novel insights into the diverse biological effects of perlecan.
Segev A; Nili N; Osherov AB; Qiang B; Wong AJ; Pillarisetti S; Strauss BH
EuroIntervention; 2010 May; 6(1):134-40. PubMed ID: 20542809
[TBL] [Abstract][Full Text] [Related]
14. YY1 directly interacts with myocardin to repress the triad myocardin/SRF/CArG box-mediated smooth muscle gene transcription during smooth muscle phenotypic modulation.
Zheng JP; He X; Liu F; Yin S; Wu S; Yang M; Zhao J; Dai X; Jiang H; Yu L; Yin Q; Ju D; Li C; Lipovich L; Xie Y; Zhang K; Li HJ; Zhou J; Li L
Sci Rep; 2020 Dec; 10(1):21781. PubMed ID: 33311559
[TBL] [Abstract][Full Text] [Related]
15. STAT3 Protein Regulates Vascular Smooth Muscle Cell Phenotypic Switch by Interaction with Myocardin.
Liao XH; Wang N; Zhao DW; Zheng DL; Zheng L; Xing WJ; Ma WJ; Bao LY; Dong J; Zhang TC
J Biol Chem; 2015 Aug; 290(32):19641-52. PubMed ID: 26100622
[TBL] [Abstract][Full Text] [Related]
16. Smooth muscle cell-specific transcription is regulated by nuclear localization of the myocardin-related transcription factors.
Hinson JS; Medlin MD; Lockman K; Taylor JM; Mack CP
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H1170-80. PubMed ID: 16997888
[TBL] [Abstract][Full Text] [Related]
17. Coronary Disease-Associated Gene
Nagao M; Lyu Q; Zhao Q; Wirka RC; Bagga J; Nguyen T; Cheng P; Kim JB; Pjanic M; Miano JM; Quertermous T
Circ Res; 2020 Feb; 126(4):517-529. PubMed ID: 31815603
[TBL] [Abstract][Full Text] [Related]
18. The smooth muscle cell-restricted KCNMB1 ion channel subunit is a direct transcriptional target of serum response factor and myocardin.
Long X; Tharp DL; Georger MA; Slivano OJ; Lee MY; Wamhoff BR; Bowles DK; Miano JM
J Biol Chem; 2009 Nov; 284(48):33671-82. PubMed ID: 19801679
[TBL] [Abstract][Full Text] [Related]
19. The actin depolymerizing factor destrin serves as a negative feedback inhibitor of smooth muscle cell differentiation.
Liao KA; Rangarajan KV; Bai X; Taylor JM; Mack CP
Am J Physiol Heart Circ Physiol; 2021 Nov; 321(5):H893-H904. PubMed ID: 34559579
[TBL] [Abstract][Full Text] [Related]
20. HERP1 inhibits myocardin-induced vascular smooth muscle cell differentiation by interfering with SRF binding to CArG box.
Doi H; Iso T; Yamazaki M; Akiyama H; Kanai H; Sato H; Kawai-Kowase K; Tanaka T; Maeno T; Okamoto E; Arai M; Kedes L; Kurabayashi M
Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2328-34. PubMed ID: 16151017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
